DIABIO — Diagonal Bio AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK18.89m
- SEK17.04m
- SEK0.02m
Annual cashflow statement for Diagonal Bio AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 41 W | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | — | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -0.583 | -11.7 | -16.2 | -11.7 |
| Non-Cash Items | — | — | — | 0 |
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.753 | 0.72 | 0.391 | 6.45 |
| Change in Other Assets | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | 0.17 | -10.9 | -15.8 | -5.23 |
| Capital Expenditures | -5.98 | -8.59 | -4.96 | -4.25 |
| Purchase / Acquisition of Intangibles | ||||
| Cash from Investing Activities | -5.98 | -8.59 | -4.96 | -4.25 |
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 9.48 | 36.6 | 13.5 | -1.14 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 3.67 | 17.1 | -7.18 | -10.6 |